SRH Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-204
Closed -$3.83K 302
2024
Q1
$3.83K Hold
204
﹤0.01% 273
2023
Q4
$2.94K Hold
204
﹤0.01% 280
2023
Q3
$3.54K Hold
204
﹤0.01% 262
2023
Q2
$4.8K Hold
204
﹤0.01% 248
2023
Q1
$5K Hold
204
﹤0.01% 248
2022
Q4
$6K Hold
204
﹤0.01% 233
2022
Q3
$5K Hold
204
0.01% 253
2022
Q2
$7K Sell
204
-21
-9% -$736 0.01% 227
2022
Q1
$8K Hold
225
0.01% 230
2021
Q4
$7K Hold
225
0.01% 244
2021
Q3
$7K Hold
225
0.01% 233
2021
Q2
$7K Buy
+225
New +$7.41K 0.01% 233

Other funds holding OGN

SRH Advisors's OGN Position: Q2 2024 in Review

SRH Advisors sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 204 shares — an estimated $3.83K sold.

SRH Advisors first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $8K in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • SRH Advisors reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • SRH Advisors sold 204 Organon & Co shares in Q2 2024, an estimated $3.83K.
  • SRH Advisors first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
  • SRH Advisors's Organon & Co position peaked at $8K in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on SRH Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.